(Q77336320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

M A Westerink

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S L Smithson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

N Srivastava

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J Blonder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

C Coeshott

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

G J Rosenthal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

711-723

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

The common mucosal immune system and current strategies for induction of immune responses in external secretions

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Mucosal immunity and tolerance: relevance to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Mucosal immunity: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

The nasal mucociliary clearance: relevance to nasal drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Drug metabolism in the nasal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Immunostimulatory DNA is a potent mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Poloxamer 407-induced atherogenesis in the C57BL/6 mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Percutaneous absorption of indomethacin from pluronic F127 gels in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Chitin biotechnology applications

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Screening of cationic compounds as an absorption enhancer for nasal drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Surface active agents as enhancers of alveolar absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Chitosan: a unique polysaccharide for drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Chitosan as a novel nasal delivery system for peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Effect of chitosan on epithelial permeability and structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Immunological activity of chitin and its derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Adjuvant activity of chitin derivatives in mice and guinea-pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900423-6

7 January 2021

10.1016/S0264-410X(01)00423-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11738734%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference